Colgate-Palmolive (CL) Earnings Date & Reports
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry... Show more
CL is expected to report earnings to fall 2.32% to 94 cents per share on July 31
Colgate-Palmolive (CL) Q1 2026 Earnings Recap: Strong Sales Growth Tops Estimates
Key Takeaways
- Net sales increased 8.4% to $5.324 billion, surpassing consensus estimates of approximately $5.23 billion.
- Organic sales grew 2.9%, driven by emerging markets despite North America declines.
- Base Business EPS (diluted earnings per share, a non-GAAP measure excluding certain charges) rose 7% to $0.97, beating expectations of $0.95.
- GAAP EPS fell 6% to $0.80 amid restructuring costs; gross profit margin dipped 20 basis points to 60.6%.
- Company expanded its Strategic Growth and Productivity Program (SGPP), targeting $200–$300 million in annual savings.
- Reaffirmed full-year organic sales growth of 1%–4% but lowered gross margin outlook to down versus prior up guidance.
Earnings Context and Why It Matters
Colgate-Palmolive's Q1 2026 results mark a solid start to the year amid persistent macroeconomic headwinds and category slowdowns. As a global leader in oral care, personal care, and pet nutrition, the company faces pressures from inflation, currency volatility, and shifting consumer behaviors. Investors closely watch these earnings for signs of pricing power, volume resilience, and margin sustainability, especially in emerging markets where growth accelerated. With shares trading near multi-year highs entering the report, the beat on top- and bottom-line figures reinforces Colgate-Palmolive's defensive stature in consumer staples, while guidance tweaks highlight ongoing cost challenges.
Colgate-Palmolive reported net sales of $5.324 billion for the first quarter ended March 31, 2026, up 8.4% from $4.911 billion a year ago and ahead of Wall Street's $5.23 billion consensus. Organic sales growth of 2.9% reflected balanced volume and pricing gains across most categories, though offset by a 0.6% drag from reduced private label pet food sales. Every division except North America posted growth, with Latin America up 14.8% and Asia Pacific up 8.9%.
GAAP diluted EPS declined 6% to $0.80 from $0.85, impacted by charges related to ERISA litigation and the SGPP. However, Base Business EPS climbed 7% to $0.97, exceeding the $0.95 forecast. Gross profit margin contracted slightly to 60.6%, pressured by higher input costs like resin. Operating profit (GAAP) fell 10% to $964 million, but advertising investments rose to $734 million. Free cash flow before dividends improved to $609 million.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your investment strategy.
Market Reaction and Investor Sentiment
Colgate-Palmolive shares rose in the wake of the Q1 results, reflecting investor approval of the sales and EPS beats despite margin softness and guidance adjustments. The stock advanced in premarket trading on May 1, underscoring confidence in the company's emerging market momentum and productivity initiatives. Sentiment remains cautiously optimistic, with focus shifting to execution amid volatile commodity prices and tariff risks.
Forward Outlook and Key Factors to Monitor
Colgate-Palmolive reaffirmed its full-year 2026 guidance, projecting net sales growth of 2%–6% (with low-single-digit FX tailwind) and organic sales of 1%–4%. GAAP EPS is expected to deliver double-digit growth, while Base Business EPS targets low to mid-single digits. Notably, gross margin outlook was revised lower to "down" from "up," citing elevated resin costs and tariff impacts as of late April.
The expanded SGPP, approved April 30, will incur $350–$550 million in pretax charges through 2028 but deliver $200–$300 million in annual savings, bolstering long-term margins. Investors should track category volumes in North America, where declines persisted, versus robust emerging market trends.
Broader dynamics include sustained advertising increases as a percentage of sales, market share gains in toothpaste (41.1% globally), and pet nutrition resilience at Hill's. Upcoming catalysts encompass Q2 results in July and progress on 2030 strategy pillars like innovation and supply chain efficiencies. Cost inflation, FX fluctuations, and geopolitical tariffs remain headwinds to monitor closely.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Advertisement
General Information
a maker of oral, personal, and household products
Industry HouseholdPersonalCare